Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I was wondering if they’ll keep disclosing each sale or they’ll just put a nr when it’s a huge order. New CEO might change how they disclose them
Nice recovery so far. Volume is good although the uptrend seems to have met some stronger resistance this week
Roadside tests are very high profile and will eventually become a good revenu stream but right now they want to monitor what will happen in court before allocating resources to product line. Here’s what the CEO said in this interview(https://investingnews.com/ceo-interviews/flurotech-ceo-danny-dalla-longa-cannabis-testing-technology/):
« We’re also monitoring roadside testing legislation. To date, one supplier has been picked and the lawyers are lined up to litigate this testing protocol on each side. We don’t want to get involved until the litigation clears, therefore, we will focus on industrial testing in the near term as it provides a much larger market opportunity. »
Besides they are trying to get that first mover advantage in the US so I’m more than OK if they can get a strong presence in the US market while waiting to see how litigations are resolved.
About Flurotech
I’ll just shamelessly copy paste the about section on the flurotech website (www.flurotech.com) to give a basic answer of what is Flurotech doing/selling, where they’re coming from and also dd that they began trading on the Venture on June 12 2018 through a reverse merger with a company named “Snow Eagle Resource”. IPO was at 0.45$ CAD
Translation for non-scientific people like myself: They sell a device named Completest that can measure many things with great precision like THC/CBD % and the presence of heavy metals in marijuana within 30 minutes which is unheard of in the industry.
The model shown here (because there will be other versions for different needs) is the one the Licensed Producers will use to measure and optimize their crop production. Although it is a scientific piece of equipment, it doesn’t take highly skilled people to operate.
Why the LPs should take notice
• It’s fast, like real fast (less than 30 minutes) which is very important because the only only options to get information about their crop is either own some very expensive (1M$+) lab equipment (HLPC, Mass Spectometry) and pay highly skilled employees to run the tests or collect some samples and send it to a remote 3rd party lab and wait anywhere between a couple days to a couple weeks depending on the current workload of the lab. You can see the huge size of the HLPC lab equipment vs the Completest in the following slide from the Flurotech presentation deck.
It’s cheaper. Flurotech aims to cut the price for testing by about 50% ( ~70$CAD/test instead of ~150 on avg for 3rd party lab).
• It’s early detection. It’s notifying the producers to remove contaminated crop ASAP. If I’m a producer, I sure do not want to wait 50-60 days to know that I need to start over my batch. Health Canada has a low tolerance for contaminants that will be smoked, because it is not possible to rid the human body of them, whereas vegetables are allowed much higher contamination levels because they are eaten which causes far less absorption issues. Completest will prevent them from losing more time and expense growing a product that can`t be sold.
• More testing means optimization of their crop. Why would the growers care? According to Flurotech, each 1% increase in THC potency give the producer an additional 8.3% additional extract revenue so if we look at the slide down there, if you grow “Cold Creek Krush” and you know that max THC potency is 17%, you can lose 8-16% of revenues if you harvest it 2-3 days sooner or too late. With Completest you can start measuring near peak time to see the potency and harvest at the exact right moment where THC % is the highest.
It’s accurate. Cross Lab variability is a thing. Problem is due to human errors, not the equipment itself. There can be a variation up to 10-20% between independent labs which is a problem because if you expect X% of THC and the lab gives you a (X-20)% THC measure of your sample then you just know that you’re selling it on the cheap. No one wants to do that. Because of that, growers usually sends multiple samples from the same batch to many labs and picks whichever lab returns the highest % value. Health Canada only cares that you have a valid independent lab result before MJ goes into sales. With Complete you don’t have that variability. In fact, variability is under 1%. Another benefit from this accuracy is that you can also modify some parameters like lights intensity and measure the effect on the plant potency. I can’t find the reference but it seems one of the beta tester of the Completest greatly increased plant potency by varying how lighting was setup.
Why investors should take notice
1. Many revenues streams:
• Flurotech has a lot of potential revenue streams and I think it’s one of the things that can make new investors lose the big picture so I’ll try to broadly categorize their slide of “Future Revenue Streams”
Growers market (See LP section earlier in this article)
o Enterprise and Law Enforcement are both interested in having a precise drug detection device. Impaired driving should be punished but testing isn’t as clear and easy as an alcohol test right now. Canada has allocated $161 million over the next five years (New roadside test to detect marijuana coming to Canada to the acquisition of devices and training of roadside tests to measure MJ. Draeger 5000 has been already approved but they intend to have multiple device providers. Not only will Flurotech`s device detect and measure MJ but also cocaine and meth!
Flurotech also has 3 (!) lobbyists registered and already at work helping the Canadian government to get a better grasp of the Flurotech products. There isn’t any communications showing on the website but I’ve followed the lobbyist’s registry for a couple months now and they are far from up to date regarding communications between companies and gov.
o Government and Law Enforcement market. Beside drug testing the authorities needs to be able to track MJ from “seed to sale”. This is something that isn’t available as we speak. Flurotech is currently developing biomarking which allow the producers to add a biomarker in the water which is then absorbed by the plant to give it a unique signature that can be decoded back by the Completest device to identify the product origin. In my opinion that feature is disruptive because it solves a problem that couldn’t be addressed before. MJ testing can be done by labs (at a higher price and slower pace), drug testing can still be found and police officers do have other techniques to identify intoxicated people but identifying which grower have produced a specific MJ sample? It’s unheard of and it’s the kryptonite the government need to fight black market and counterfeit products. Once a police car has the biomarket testing equipment, it is only $6k more to get a breathalyzer tester t o attach to it, so there are economies of scale for police forces to buy it all from Flurotech.
2. According to Flurotech, the market scope is large and growing exponentially
o In Canada alone, there are about ~135 LP
o USA (thanks to the US Farm Bill) supposedly 100 000 growers
o Worldwide is even crazier.
3. Their pricing model is similar to the razor-razor blades model as they’ll get recurring yearly (~20K$/year/unit estimated) but they also get a good profit on the device itself which they sell for around 31k$. The great thing about that, is it’s still a good deal for producers and also most growers don’t already own any existing piece of equipment for that need (well beside the majors who already owns 1M$+ lab equipment). Lastly since it’s a new industry, most growers have cash on hand.
4. Things are heating up in Q1 and Q2
• 2018 has been kind of a dull year and the hype has pretty much died down when we reached the end of the year. News releases were sparse and nothing was feeling like a major breakthrough but it was a crucial period as they were beta testing the Completest device with 15-20 producers, integrating feedback and making improvements to the device while developing roadside testing and biomarker in background. CSA told them they had to wait until MJ was legal before they would start to look at their application to get the certification. They finally got it on February 5th and announced start of the sales at the same time. The table below retraces the public news/events/articles/videos that happened since their beginning classified into broad categories of lesser and great. Take this lightly:
Most of the news in 2018 has been uneventful science and hires updates but there are 3 things I want to highlight:
• There was a trading Halt on the stock because of some clerical error caused by the reverse-merger regarding the end of the financial year. It happens sometimes but it did look bad at the time. Everything was filed again correctly in the following days so it I don’t see any reason to discuss more about that.
• Hiring of Trevor Macmillan, Aurora’s former Chief Scientist the 10B$ cannabis company on the Toronto Stock Exchange. This move might have been seen as another lateral career move by a scientific in the industry but Flurotech in my opinion gained a lot of credibility by hiring this guy. He might not be the greatest gifted speaker as we can see in the latest Midas video and the 1 hour webinar on youtube but it doesn’t matter because the scientific and cannabis communities listens when he speaks. I’m very pleased to see him on the Flurotech payroll as he leads the biomarking project right now.
• One tidbit I noted in the Nov 28th MD&A was that Flurotech was building more Completests for their first batch (seems now like they will keep 10 for testing) which is a sign that demand is there for the product.
2019 mindset is completely different.
• CSA and UL certifications are now officially over and they started the sales. I expect them to have an easy 15-20 devices to beta testers from 2018 and after that who knows?
• Flurotech is now in full PR mode. Because of the official start of the sales, they seem to be ready to tell their story to the world which wasn’t necessarily the case when they were beta-testing it and waiting for CSA approval. When you regroup news and updates by month it’s becoming even clearer that things are heating up and they want the investors to notice and they actually do because volume has been steadily increasing since January and at march 8 the volume is already at 72% of what it was for the complete month of February according to Yahoo Finance volume stats
• A private placement will happen down the road. They don’t hide that they’ll eventually get back to the market to fund an expansion in other juridictions (US). It won’t be cheap because if the market potential is really 100k growers requiring the device as much as they say, then they’ll need to have a decent inventory before starting to sell. I’ve made a small table, just to have a feel on what to expect considering what I know and what I think should happen. It’s a guesstimate, overly optimistic and only there to make the point of why they need to go back to the market someday so don’t take it too seriously - I don’t have any inside info.
o Notes
They have around 5M$ in the bank at the start of Feb
They have 3 salespeople so at 30 unit sold it’s about 1 unit/2business day/salesman. It’s optimistic, I know.
The headcount is 35 employees at the end of Feb. I didn’t include any new hiring which is also not realistic.
They have a 500k$ monthly burn rate. It’ll raise over time but for the exercice, I’ve put it as a constant capex
All units are sold with the 2 scopes for 31k$ (will probably not be the case in real life)
Recurring revenues are at their expected maximum usage which is 20K$/unit/year so 1.6K$/unit/month
As I remember, putting a unit together is about 10K$
I included a Private Placement (PP) of 20M$ to finance growth (10M$ to build a 1000 Completests inventory and the other 10M$ is for staff and general expense). These numbers are purely guesses from me.
July is the month where they would enter US (and keep selling in Canada) in this fictive scenario
I guess what I see is that they’ll need a decent inventory when hitting the US and build a thousand Completest means around 10M$ cash up-front. 20M$ might be a bit high for a PP and 1000 Completest might be high when considering they do have for ~10M$ in warrants at an avg 0.57$ if all converted but there will be a point in time this spring where a placement will occur. I doubt that anyone will complain if they can raise money over 1.50$ because after that the float would be around 100M shares fully diluted so it isn’t that bad but I think they are aiming for higher and they have the cash right now to be patient about it and see where the share price is heading.
What about competitors?
Frankly there’s not much competition. I had to dig into an old pre-Flurotech (Cannatest) presentation to get some companies that might be called competitors. FYI before it was called Completest, the name was OptiQ.
• Cannalyzer (http://www.cannalyzer.ca/)
o Website doesn’t give us much details but they state that potency results can be obtained in less than 48 hours so it’s still slow
• TRIQoptiq (http://www.triqsystems.com)
o Only reference I could find is a facebook post dating from 2013 and their website looks down
• Lightlab (https://www.orangephotonics.com/)
o This one might be the most direct competitor to Flurotech. At first sight their device looks somewhat similar (and cost less) although they can’t test for heavy metals, pesticides and others contaminants. That means that a grower would still send samples to a lab to know about heavy metals. Consumables and services (calibration, warranty) seems more expensives than Flurotech so long term I’m not sure it’s a better deal because you’ll still need to test contaminants (and rely to a slow and costly alternative) and if your goal is to test as much as you can then Completest is a cheaper long term option and you won’t be able to add new scopes Flurotech will develop to check other things like mould or Aflatoxin.
• Cannalytics (https://www.cannalyticssupply.com/)
o 99USD/test and sensitivity look very low as the slide says
• Steep Hill Lab and Analytical 360 are labs so I won’t even bother.
Other interesting notes (at least for me) and speculation
• Insiders have not sold a single share yet. In fact CEO converted 250k warrants in February
• Once GMP certification is obtained, independent 3rd party could basically buy and use a Completest device to the testing instead of using HLPC equipment. Health Canada only requires that tests are made by an independent lab with GMP equipment.
• Right now shorts have left the building (www.shortdata.ca)so I do feel that selling pressure is less oppressive
• CEO Dan Dalla Long is an ex politician. He was elected to the Legislative Assembly of Alberta. I think it’ll serve the company well because they’ll need to interact a lot with the government on different level. The fact that they have 3 registered lobbyists for a 30M$ market cap company is telling me they are doing it the right way.
• There is around ~17M warrants (avg ~0.57$) which isn’t that bad plus there is the following acceleration clause(from Sedar Interim Audited Financial report):
“If the volume weighted average closing price of the Common Shares is $1.00 or more for 10 consecutive trading days at any time after six months from the date of issuance of the Warrants the Corporation will earn the right, by providing notice (the "Acceleration Notice") to the Warrant holders, to accelerate the expiry date of the Warrants to that date which is 30 days from the date of the Acceleration Notice “
• DEA put out a request to find manufacturer of a Hemp Testing kit and a week later Flurotech issue a News release about the US and finishing their Hemp testing kit. I don’t believe much in coincidence so I’m going to speculate that they must be well aware of this opportunity.
Why I feel this company is undervalued
• I’ll concede that they were very low key during last half of 2018. They were in beta mode, anything could have happened and sometimes it’s just better to fine tune and improve your product instead of going on an empty promise PR campaign.
• I also think they came late to the MJ sector. Once legalization was made on October 17th most MJ stock tanked until late January of this year so they didn’t enjoyed the free ride many other MJ stocks had in the market.
• Most investors are overestimating the Roadside testing revenues potential and underestimating the LPs need for testing. To me it’s pretty obvious that LPs will be the bulk of the revenues for years to come.
LPs testing > Biomarking > Enterprise Testing > Roadside testing.
It just blow my mind away that a company like Cannabix technology can have and sustain a 130M$+ market cap with zero product commercially ready while Flurotech is sitting at 30M$ market cap with an actual product when they are expecting to sell hundreds and even thousands (with the US and Rest of the World). I don’t get it and it’s not a shot a people who believe in Cannabix, it might be justified but if that’s the case then I don’t see how Flurotech can trade for less than a 100M$ market cap at the moment. Either Cannabix is grossly overvalued or Flurotech is extremely undervalued (which I believe it is).
• It’s a new company: they have money, 0 debt, filled with credible management and scientists in one of the hottest sector on the market.
In conclusion
I hope I helped some investors to get a better understanding of the company and hopefully you’ll find this company interesting enough to follow it. I think they have set the stage and media outlet to get their story and message to the investors in 2019.
Disclosure: I am/we are long FLURF.
I originally posted this on SeekingAlpha at :
https://seekingalpha.com/instablog/41685036-helloimx/5279815-flurotech-nextgen-cannabis-testing-device
Ahead of the heard newsletter has an article about Flurotech:
https://aheadoftheherd.com/Newsletter/2019/Cannabis-testing-the-new-frontier.htm
Small dip this am. Probably will recover in the afternoon.
The application form :
https://www.fbo.gov/index.php?s=opportunity&mode=form&id=a3844903bd67d105c04761013f06ef0f
Article from another site without a paywall:
https://news.weedmaps.com/2019/03/dea-calls-for-machine-that-can-detect-difference-between-hemp-marijuana/
WEEDMAPS · NEWS · LAW & POLITICS
DEA Calls for Machine that Can Detect Difference Between Hemp, Marijuana
Marijuana Moment · March 7, 2019
The Drug Enforcement Administration (DEA) is actively looking for a device that it can use to determine whether a given cannabis plant is federally legal hemp or still-prohibited marijuana.
In a “sources sought” notice published in late February 2019, the agency said that the 2018 Farm Bill, which federally legalized industrial hemp and its derivatives, made it necessary to find “vendors in the marketplace” that have developed such field kits.
The device “must provide specificity to distinguish between hemp and marijuana,” according to the notice.
Device...must provide specificity to distinguish between hemp and marijuana. CLICK TO TWEET
“It must be portable and rugged enough to be used in non-laboratory environments or ambient conditions. All products shall be the most current and up-to-date model/revision(s) available at the time of delivery. Anticipated maximum quantities to be purchased will be based on evaluation results and agency need.”
While the 2018 Farm Bill shifted regulatory responsibility for hemp from the Justice Department to the U.S. Department of Agriculture (USDA), Justice's law enforcement units such as the DEA are still charged with enforcing federal marijuana laws, and such technology could simplify their enforcement efforts.
In the notice, the DEA made a point of emphasizing that “[a]ny Cannabis sativa L. plant material with a THC concentration above 0.3 percent is considered marijuana (AKA marihuana) and is still federally controlled.”
Businesses are invited to submit information about potential field kits to help DEA “facilitate the decision-making process in acquisition planning.” The response deadline for the notice is March 15, 2019.
Meanwhile, the DEA is still under pressure from lawmakers to approve applications for additional manufacturers of research-grade marijuana. The agency said in December 2018 that it “continues to review” the applications.
This article has been republished from Marijuana Moment under a content syndication agreement. Read the original article here.
Just read an article on Globe and Mail that says the DEA wants to have a machine capable of correctly discriminate between Hemp and illegal cannabis. March 15 is the deadline for application.
https://www.theglobeandmail.com/robcannabispro/article-around-the-industry-for-march-8/
Seems like Flurotech efforts to promote the company through CFN and other outlets is working. Volume in 2019/month
Jan:707K
Feb:1.89M
Mar: 1.18M (on march 7)
We’ll probably break feb volume by mid-march.
2019-03-07 07:30:00
FluroTech Files Expedited Examination at USPTO and Updates Global Patent Strategy
CALGARY, Alberta, March 07, 2019 (GLOBE NEWSWIRE) -- FluroTech Ltd. (TSX-V: TEST) (OTCQB: FLURF), (“FluroTech” or the “Company”) is pleased to announce that a favorable Written Opinion (“WO”) has been received for Patent Cooperation Treaty (“PCT”) Patent Application No. CA2018/051387 (the “PCT Application”). The PCT Application entered national phase in the United States Patent and Trademark Office (the “USPTO”) on November 2, 2018. In the WO all 58 pending claims as filed were both novel and inventive. Based on this favorable WO, a request for accelerated examination may be filed at the USPTO. A request for accelerated examination of claims 1 to 32 was filed at the USPTO on March 6, 2019. The remaining claims 33 to 58 of the PCT Application have not yet been filed at the USPTO but may be filed in a continuation application at the USPTO.
The Company holds exclusive, irrevocable rights for application of the subject matter of the PCT Application and the US Application for use globally in the hemp and cannabis industry. In addition to the national phase entry in the United States, the PCT Application may be filed in any additional member states of the PCT, which currently includes 152 countries.
The CompleTestTM hemp and cannabis testing device applies technology to improve signal stability in the face of thermal and other fluctuations in the light source, which in turn facilitates improved sensitivity and accuracy, particularly for portable instruments. The technology applied in the CompleTestTM device is claimed in the pending PCT Application and US Application.
“The Canadian Intellectual Property Office acting as International Search Authority found no issued patents or published applications describing or making obvious the proprietary technology applied in the CompleTestTM system and claimed in the patent applications. This positive outcome at the international PCT stage, provides access to accelerated examination of all 32 claims filed in the United States. A continuation application including the other 26 claims that were found novel and inventive at the PCT stage and can also be filed in the United States, and accelerated examination will be available for those claims as well,” stated Dr. Elmar Prenner, Chief Technology Officer at FluroTech. “Additionally, the Company is developing technology for biomarking and is working with our legal counsel to draft and file patent applications protecting that technology, expanding the patent portfolio and supporting FluroTech’s commercialization of a second line of business.”
Developments on other advanced designs for future generations of the CompleTestTM system to maintain the Company's technical lead are in progress.
“FluroTech believes it is emerging as a leader in the cannabis and hemp-house testing space with the development of badly needed technology to improve accuracy and repeatability. We believe with our data that we are meeting that need,” commented Danny Dalla-Longa, Chief Executive Officer at FluroTech. “Global regulation, rather than prohibition, of cannabis and hemp-flower products, and particularly loosening regulations around CBD products in certain countries, is encouraging FluroTech to leverage its global patent strategy. The export and import of analytical testing devices such as CompleTestTM system are not highly regulated, which increases the global testing market the Company can access. The Company is contemplating licensing opportunities in additional geographical jurisdictions and is in negotiations with international distributors to allow for quick sales expansion of the CompleTestTM system.”
About the CompleTest™ System
The CompleTest™ system is FluroTech’s flagship brand and product line. The CompleTest™ system is a portable, cost-effective, state-of-the-art hemp and cannabis testing device, able to provide fast, accurate and consistent testing results. It is designed for cultivators, processors, nurseries, researchers, other federal licensees, and even individuals with an interest in optimizing phytocannabinoid yield or consumer safety of cannabis products.
AboutFluroTech (TSX-V: TEST) (OTCQB: FLURF)
FluroTech is a technology and marketing company whose core business is focused on the commercialization of new technologies in the cannabis industry. FluroTech’s proprietary spectroscopy-based technology allows for the testing and identification of organic and inorganic compounds contained within biological samples. Using the technology that was developed in part at the University of Calgary, FluroTech has developed a two-part solution comprising an instrument called the CompleTest™ system and consumable testing kits for the CompleTest™ system.
To learn more, visit www.FluroTech.com.
Contact Information
Danny Dalla-Longa
Chief Executive Officer
403.680.0644
danny@flurotech.com
FluroTech Ltd.
Alistair Ross Technology Centre
Suite 111, 3553-31 Street NW
Calgary, AB T2L 2K7
info@flurotech.com
This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities. The securities described herein have not been and will not be registered under the United States Securities Act of 1933, as amended, or the securities laws of any state and may not be offered or sold within the United States or to or for the benefit or account of U.S. persons, absent such registration or an applicable exemption from such registration requirements.
Cautionary Statement Regarding Forward-Looking Information
This news release contains "forward-looking information" within the meaning of Canadian securities legislation. Forward-looking information generally refers to information about an issuer’s business, capital, or operations that is prospective in nature, and includes future-oriented financial information about the issuer’s prospective financial performance or financial position. The forward-looking information in this news release includes disclosure about the filing of a continuation application in respect of certain of the claims, the filing of the PCT application in additional member states of the PCT, the benefits of the WO to the Company, the development of the Company’s biomarking and the intellectual property strategy in connection therewith, development for advanced designs for future generations of the Company’s technology, the Company’s position as a leader in the cannabis testing space, the U.S. and global hemp market opportunity for the CompleTestTM system, FluroTech’s ability to expand the addressable market, the ability to develop a hemp testing protocol and the timing of the protocol completion and future licensing opportunities for the Company.
The Company made certain material assumptions, including but not limited to prevailing market conditions and general business, economic, competitive, political and social uncertainties, the need and demand for hemp testing protocol utilizing the CompleTestTM system in the U.S. and globally, the continuation of the trend of regulating and not prohibiting cannabis and hemp-flower products, including CBD and the success of future intellectual property filings, to develop the forward-looking information in this news release. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.
Actual results may vary from the forward-looking information in this news release due to certain material risk factors. These risk factors include, but are not limited to, adverse market conditions and regulatory and other risks associated with the cannabis and hemp industry in general, users of the Company’s CompleTestTM system and the CompleTest™ system failing to achieve the anticipated benefits of the product, changes to the anticipated regulatory regime in respect of the cannabis and hemp industry, competition from other developers of similar technology, failure to obtain patent or other intellectual property protection for the company, failure to reach commercialization of the technology and failure for the products anticipated market to develop. The Company cautions that the foregoing list of material risk factors and assumptions is not exhaustive.
The Company assumes no obligation to update or revise the forward-looking information in this news release, unless it is required to do so under Canadian securities legislation.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy of this release.
2019-03-07 07:30:00
FluroTech Files Expedited Examination at USPTO and Updates Global Patent Strategy
CALGARY, Alberta, March 07, 2019 (GLOBE NEWSWIRE) -- FluroTech Ltd. (TSX-V: TEST) (OTCQB: FLURF), (“FluroTech” or the “Company”) is pleased to announce that a favorable Written Opinion (“WO”) has been received for Patent Cooperation Treaty (“PCT”) Patent Application No. CA2018/051387 (the “PCT Application”). The PCT Application entered national phase in the United States Patent and Trademark Office (the “USPTO”) on November 2, 2018. In the WO all 58 pending claims as filed were both novel and inventive. Based on this favorable WO, a request for accelerated examination may be filed at the USPTO. A request for accelerated examination of claims 1 to 32 was filed at the USPTO on March 6, 2019. The remaining claims 33 to 58 of the PCT Application have not yet been filed at the USPTO but may be filed in a continuation application at the USPTO.
The Company holds exclusive, irrevocable rights for application of the subject matter of the PCT Application and the US Application for use globally in the hemp and cannabis industry. In addition to the national phase entry in the United States, the PCT Application may be filed in any additional member states of the PCT, which currently includes 152 countries.
The CompleTestTM hemp and cannabis testing device applies technology to improve signal stability in the face of thermal and other fluctuations in the light source, which in turn facilitates improved sensitivity and accuracy, particularly for portable instruments. The technology applied in the CompleTestTM device is claimed in the pending PCT Application and US Application.
“The Canadian Intellectual Property Office acting as International Search Authority found no issued patents or published applications describing or making obvious the proprietary technology applied in the CompleTestTM system and claimed in the patent applications. This positive outcome at the international PCT stage, provides access to accelerated examination of all 32 claims filed in the United States. A continuation application including the other 26 claims that were found novel and inventive at the PCT stage and can also be filed in the United States, and accelerated examination will be available for those claims as well,” stated Dr. Elmar Prenner, Chief Technology Officer at FluroTech. “Additionally, the Company is developing technology for biomarking and is working with our legal counsel to draft and file patent applications protecting that technology, expanding the patent portfolio and supporting FluroTech’s commercialization of a second line of business.”
Developments on other advanced designs for future generations of the CompleTestTM system to maintain the Company's technical lead are in progress.
“FluroTech believes it is emerging as a leader in the cannabis and hemp-house testing space with the development of badly needed technology to improve accuracy and repeatability. We believe with our data that we are meeting that need,” commented Danny Dalla-Longa, Chief Executive Officer at FluroTech. “Global regulation, rather than prohibition, of cannabis and hemp-flower products, and particularly loosening regulations around CBD products in certain countries, is encouraging FluroTech to leverage its global patent strategy. The export and import of analytical testing devices such as CompleTestTM system are not highly regulated, which increases the global testing market the Company can access. The Company is contemplating licensing opportunities in additional geographical jurisdictions and is in negotiations with international distributors to allow for quick sales expansion of the CompleTestTM system.”
About the CompleTest™ System
The CompleTest™ system is FluroTech’s flagship brand and product line. The CompleTest™ system is a portable, cost-effective, state-of-the-art hemp and cannabis testing device, able to provide fast, accurate and consistent testing results. It is designed for cultivators, processors, nurseries, researchers, other federal licensees, and even individuals with an interest in optimizing phytocannabinoid yield or consumer safety of cannabis products.
AboutFluroTech (TSX-V: TEST) (OTCQB: FLURF)
FluroTech is a technology and marketing company whose core business is focused on the commercialization of new technologies in the cannabis industry. FluroTech’s proprietary spectroscopy-based technology allows for the testing and identification of organic and inorganic compounds contained within biological samples. Using the technology that was developed in part at the University of Calgary, FluroTech has developed a two-part solution comprising an instrument called the CompleTest™ system and consumable testing kits for the CompleTest™ system.
To learn more, visit www.FluroTech.com.
Contact Information
Danny Dalla-Longa
Chief Executive Officer
403.680.0644
danny@flurotech.com
FluroTech Ltd.
Alistair Ross Technology Centre
Suite 111, 3553-31 Street NW
Calgary, AB T2L 2K7
info@flurotech.com
This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities. The securities described herein have not been and will not be registered under the United States Securities Act of 1933, as amended, or the securities laws of any state and may not be offered or sold within the United States or to or for the benefit or account of U.S. persons, absent such registration or an applicable exemption from such registration requirements.
Cautionary Statement Regarding Forward-Looking Information
This news release contains "forward-looking information" within the meaning of Canadian securities legislation. Forward-looking information generally refers to information about an issuer’s business, capital, or operations that is prospective in nature, and includes future-oriented financial information about the issuer’s prospective financial performance or financial position. The forward-looking information in this news release includes disclosure about the filing of a continuation application in respect of certain of the claims, the filing of the PCT application in additional member states of the PCT, the benefits of the WO to the Company, the development of the Company’s biomarking and the intellectual property strategy in connection therewith, development for advanced designs for future generations of the Company’s technology, the Company’s position as a leader in the cannabis testing space, the U.S. and global hemp market opportunity for the CompleTestTM system, FluroTech’s ability to expand the addressable market, the ability to develop a hemp testing protocol and the timing of the protocol completion and future licensing opportunities for the Company.
The Company made certain material assumptions, including but not limited to prevailing market conditions and general business, economic, competitive, political and social uncertainties, the need and demand for hemp testing protocol utilizing the CompleTestTM system in the U.S. and globally, the continuation of the trend of regulating and not prohibiting cannabis and hemp-flower products, including CBD and the success of future intellectual property filings, to develop the forward-looking information in this news release. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.
Actual results may vary from the forward-looking information in this news release due to certain material risk factors. These risk factors include, but are not limited to, adverse market conditions and regulatory and other risks associated with the cannabis and hemp industry in general, users of the Company’s CompleTestTM system and the CompleTest™ system failing to achieve the anticipated benefits of the product, changes to the anticipated regulatory regime in respect of the cannabis and hemp industry, competition from other developers of similar technology, failure to obtain patent or other intellectual property protection for the company, failure to reach commercialization of the technology and failure for the products anticipated market to develop. The Company cautions that the foregoing list of material risk factors and assumptions is not exhaustive.
The Company assumes no obligation to update or revise the forward-looking information in this news release, unless it is required to do so under Canadian securities legislation.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy of this release.
Besides they choose to put the roadside tests on the back burner and focus on the Hemp Testing kit.
We have still to gain 30%+ to get to the all time high despite start of sales. Can’t think of a good reason to why we aten’t there yet since sales has begun..
Key notes from that interview:
-They’ve kind of slowed down on roadside testing device and focus on enterprise while waiting to see how litigations plays out with the Draeger 5000. Pretty wise move imo
-they don’t want to replace certified labs. It’s a tool for growers to better understand what they have and increase yields
-GMP certification is important for credibility and adoption of the device. Down the road it also potentially means that LPs could skip independant verification at certified labs
Q3=US market=100k growers market. Even 5% of that market would turn this company into a monster
2019-03-04 09:23:00
Flurotech applauds passing of U.S. farm bill
Mr. Danny Dalla-Longa reports
U.S. HEMP LEGALIZATION EXPANDS MARKET FOR FLUROTECH S COMPLETEST
Flurotech Ltd. has recognized the burgeoning market for the CompleTest hemp and cannabis testing device with a notable industry opportunity brought about by the signing of the 2018 United States farm bill.
The Agriculture Improvement Act of 2018, commonly referred to as the 2018 U.S. Farm Bill, removes the long-held legal implications, stigma and ambiguity surrounding the American hemp industry.
Changes to the U.S. Farm Bill included removing hemp from the Controlled Substances Act, means it is no longer an illegal substance under federal law. Despite belonging to the same species as cannabis, hemp has no psychoactive effects. Under the 2018 U.S. Farm Bill, a hemp plant must contain less than 0.3 per cent tetrahydrocannabinol ("THC").
"With the U.S. Federal legalization of hemp, FluroTech is able to expand its addressable market in North America to the U.S. and progress its goal to be the preferred in-house precision testing device for hemp and cannabis growers globally," commented Danny Dalla-Longa. "Hemp is difficult to distinguish from cannabis with THC from appearance and scent. We anticipate that in addition to growers, law enforcement and other regulators will require devices that can accurately distinguish the two products."
According to industry analysts at Brightfield Group, the hemp-derived cannabidiol ("CBD") market in the U.S. is expected to quickly go mainstream and become a $5.7 billion market by next year and growing to a $22 billion market by 2022. Ensuring high quality hemp is produced with known THC and CBD concentrations, and free of heavy metals, pesticides and mold, will be required by consumers of hemp-based human foods and animal supplements. The Company plans to have its hemp test protocol completed in Q2 2019 and to enter the American market shortly thereafter.
CBD can be found in varieties of the cannabis plant, including hemp plants. CBD does not produce a high or intoxicating effect. However, there is some evidence that CBD may influence some of the effects that THC has on the brain. CBD is also being studied for its possible therapeutic uses; it has received market approval in the U.S. for two severe forms of epilepsy.
About CompleTest{A } CompleTest{A } is FluroTech's flagship brand and product line. CompleTest{A } is a portable, cost-effective, state-of-the-art hemp and cannabis testing device, able to provide fast, accurate and consistent testing results. It is designed for cultivators, dispensaries and anyone with an interest in optimizing potency yield and consumer safety to test the quality and safety of their cannabis products.
About FluroTech (TSX-V: TEST ) (OTCQB: FLURF ) FluroTech is a technology and marketing company whose core business is focused on the commercialization of new technologies in the cannabis industry. FluroTech's proprietary spectroscopy-based technology allows for the testing and identification of organic and inorganic compounds contained within biological samples. Using the technology that was developed at the University of Calgary, FluroTech has developed a two-part solution comprising an instrument called the CompleTest{A } and consumable testing kits. To learn more, visit www.FluroTech.com .
We seek Safe Harbor.
Based on what we know from the device that growers will use, a test should cost around 70$ CAD. Device wil probably cost 31k$CAD to acquire, maybe less if there is only one scope used in it.
Still underwhelming considering the potential but it’s a start
Another video where Rex is saying basically the same thing over again:
So Flurotech online presence since 2019
- CFN Media (US)
- PR contract with iHub
- SmallCap Power live Webinar
- Lift & Co expo
- Still listed on the investor News Network
- 2 additional videos on Midas Newsletter
- Going to do presentation to a Thinking North event on Feb 28th
- Article in the high! Canada Magazine
I guess once sales figures starts to show, these outlets presence will start to payoff
2 new videos appeared:
CEO converted 250k warrants at .35. A non-event but it’s nice to see that there is zero share sold by insider since the IPO
Midas newsletter update ~25min
Lesser news came out this week. Looks like sales might be the only thing that’ll move the sp.
They have 3 salesmen, initially 80 devices to sell and building the next 200 should take a couple weeks. Not sure how they’ll manage sales report but I would expect them to announce the 200 order before running out of completest. I’m hoping that they’ll sell their first 80 in a 4-6 weeks but it’s would be best case scenario imo considering that their customers are close geographically and that on-site training isn’t required. If it’s the case then I would expect them to announce the 200 order in 2-3 weeks.
According to the latest update they made to their presentation they had 4.5M$ in the bank at jan 31. So enough to keep going and build that new batch.
According to this tweet they’ll be presenting on feb 28th: https://twitter.com/thinkingnorth/status/1096080312520622081?s=21
Think: #Cannabis for Big Returns is happening Feb 28th at @gowlingwlg_ca!
We're pleased to announce our presenting companies:
FluroTech Ltd.
@Cannarabiotech
AAA Medic Montreal Inc.
Groundlevel Insights
Title Sponsor: AgraFlora
#ThinkingNorth #cannabisnews #cannabisevent
Calgary, Alberta, February 11, 2019 – FluroTech Ltd. (TSX-V: TEST) (OTCQB: FLURF), (“FluroTech” or the
“Company”) is pleased to announce that the CompleTest™ was selected as the best of show for new cannabis
technology by High! Canada Magazine at the recent Vancouver LIFT Expo.
“The award was unexpected,” commented Gary Jones, VP Business Development at FluroTech. “The Vancouver
LIFT Expo was the first time FluroTech unveiled the CompleTest™ to the public. Master growers and quality
assurance personnel were impressed by the live demonstrations, which reaffirmed the confidence the Company
has in the technology. Feedback was positive with respect to the simplicity, speed, accuracy, and consistency of
results of the product. Master growers recognized that they could affordably and accurately use the in-house
testing device to select mother plants for breeding or to optimize their potency yield for a given strain.”
The Company believes that a fast, reliable, accurate and easy-to-use in-house testing device is required in the
cannabis industry so that growers can focus on precision agriculture and optimize the potency yield of their crop,
without waiting for outside quality assurance personnel or third-party lab results. Moreover, licensed producers
will have data at their fingertips to ensure third-party labs are providing accurate and consistent results.
The Company has launched sales of CompleTestTM and is focusing its sales efforts in Western Canada.
About CompleTest™
CompleTest™ is FluroTech’s flagship brand and product line. CompleTest™ is a portable, cost-effective, stateof-the-art cannabis testing device, able to provide fast, accurate and consistent testing results. It is designed for
cultivators, dispensaries and anyone with an interest in precision agriculture to optimize potency yield and
consumer safety to test the quality and safety of their cannabis products.
About FluroTech (TSX-V: TEST) (OTCQB: FLURF)
FluroTech is a technology and marketing company whose core business is focused on the commercialization of
new technologies in the cannabis industry. FluroTech’s proprietary spectroscopy-based technology allows for the
testing and identification of organic and inorganic compounds contained within biological samples. Using the
technology that was developed at the University of Calgary, FluroTech has developed a two-part solution
comprising an instrument called the CompleTest™ and consumable testing kits.
To learn more, visit www.FluroTech.com.
Contact Information
Gary Jones
VP Business Development
403.650.9277
gpjones@flurotech.com
Danny Dalla-Longa
Chief Executive Officer
403.680.0644
danny@flurotech.com
FluroTech Ltd.
Alistair Ross Technology Centre
Suite 111, 3553-31 Street NW
Calgary, AB T2L 2K7
info@flurotech.com
I was told ot was strictly sofware upgrade so nothing to change on the device itself
From high magazine. Seems like a retranscript of the video
https://docs.wixstatic.com/ugd/79cd39_b848074bcc9c472bb265db92ec498a1f.pdf
Now that this painful wait is over let's recap what's ahead:
1- Sales update obviously. Not sure how often they'll update but I would expect a nr when they order their 200 Completest batch after the first 80 have been sold out.
2- US campaign with CannabisFN. It's too obvious now bc the update before had a CFN video and this morning the CFN website picked up the Flurotech news. Add that they got the UL certification for the US then it's a given.
3- Update on roadside test with government. They had it for over 2 months now, so I expect a decision sooner than later
4- Biomarking update. a true game-changer to for the government to control the illegal product. According to the presentation a demo should to the gov should happen in Q1
5- GMP certification. Basically if they get this they can free the LPs of dealing with labs as long as they follow the GMP inside their building
6- I heard that some companies were interested to get completests for employees testing. Don't know if it'll happen soon but the device is there and ready to be sold
7- US market expansion. 100 000 LPs potential.
FLUROTECH ANNOUNCES PRODUCT CERTIFICATION AND COMMENCEMENT OF SALES
Calgary, Alberta, February X, 2019 – FluroTech Ltd. (TSX-V: TEST) (OTCQB: FLURF), (“FluroTech” or the “Company”) is pleased to announce that both the desktop and portable CompleTestTM devices, along with the related heavy metal and THCa and CBDa scopes, have been evaluated by LabTest Certification Inc. and have received the applicable Canadian Standards Association (“CSA”) and Underwriters Laboratories (“UL”) product safety certifications for North America. With certifications in-hand, the Company has commenced sales activities.
“FluroTech is committed to selling high quality products that are safe and reliable. We are proud that the design of the desktop and portable CompleTestTM devices and scopes meet all applicable safety standards set out by CSA and UL.” commented Danny Dalla-Longa, Chief Executive Officer of FluroTech. “In addition to the CSA and UL certification, all CompleTestTM devices undergo robust internal quality controls and quality assurance to ensure uniformity between devices.”
Over the past year, in-house evaluation has resulted in the collection of thousands of datapoints demonstrating that accurate, repeatable and reliable results can be achieved with the CompleTestTM. Numerous workshops have also been completed with both internal and external participants to refine the CompleTestTM training programs and ensure the device is easy-to-use.
“We have completed the design verification, testing, and certification of CompleTestTM and are excited to launch into a high growth market” stated Gary Jones, Vice President of Business Development. “The CompleTestTM was unveiled to master growers and quality assurance personnel at the recent Lift Expo in Vancouver, where over 60 live demonstrations were completed demonstrating the capabilities of our devices. The Company received positive feedback from the attendees in respect of with the simplicity, speed, accuracy, and consistency of results of the product. The Company believes that The CompleTestTM provides growers with an in-house quality assurance solution that also provides the opportunity to optimize and manage potency yields of cannabis.”
With a fast, reliable, accurate and easy-to-use in-house testing device, growers can focus on precision agriculture and optimize the potency yield of their crop without waiting for quality assurance personnel or third-party lab results. Moreover, licensed producers will have data at their fingertips to ensure third-party labs are providing accurate and consistent results.
About CompleTestTM
CompleTestTM is FluroTech’s flagship brand and product line. CompleTestTM is a portable, cost-effective, state- of-the-art cannabis testing device, able to provide fast, accurate and consistent testing results. It is designed for cultivators, dispensaries and anyone with an interest in precision agriculture to optimize potency yield and consumer safety to test the quality and safety of their cannabis products.
About FluroTech (TSX-V: TEST) (OTCQB: FLURF)
FluroTech is a technology and marketing company whose core business is focused on the commercialization of new technologies in the cannabis industry. FluroTech’s proprietary spectroscopy-based technology allows for the testing and identification of organic and inorganic compounds contained within biological samples. Using the technology that was developed at the University of Calgary in conjunction with the University of Alberta, FluroTech has developed a two-part solution comprising an instrument called the CompleTestTM and consumable testing kits.
NOT FOR DISTRIBUTION TO THE UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
To learn more, visit www.FluroTech.com. Contact Information
Gary Jones
VP Business Development 403.650.9277 gpjones@flurotech.com
Danny Dalla-Longa Chief Executive Officer 403.680.0644 danny@flurotech.com
FluroTech Ltd.
Alistair Ross Technology Centre Suite 111, 3553-31 Street NW Calgary, AB T2L 2K7 info@flurotech.com
http://www.globenewswire.com/news-release/2019/02/05/1710664/0/en/FluroTech-Announces-Product-Certification-and-Commencement-of-Sales.html
FluroTech Announces Product andCertification Commencement of Sales
05 févr. 2019 08h45 HE | Source : FluroTech Ltd.
NOT FOR DISTRIBUTION TO THE UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
CALGARY, Alberta, Feb. 05, 2019 (GLOBE NEWSWIRE) -- FluroTech Ltd. (TSX-V: TEST) (OTCQB: FLURF), (“FluroTech” or the “Company”) is pleased to announce that both the desktop and portable CompleTest™ devices, along with the related heavy metal and THCa and CBDa scopes, have been evaluated by LabTest Certification Inc. and have received the applicable Canadian Standards Association (“CSA”) and Underwriters Laboratories (“UL”) product safety certifications for North America. With certifications in-hand, the Company has commenced sales activities.
“FluroTech is committed to selling high quality products that are safe and reliable. We are proud that the design of the desktop and portable CompleTest™ devices and scopes meet all applicable safety standards set out by CSA and UL.” commented Danny Dalla-Longa, Chief Executive Officer of FluroTech. “In addition to the CSA and UL certification, all CompleTest™ devices undergo robust internal quality controls and quality assurance to ensure uniformity between devices.”
Over the past year, in-house evaluation has resulted in the collection of thousands of datapoints demonstrating that accurate, repeatable and reliable results can be achieved with the CompleTest™. Numerous workshops have also been completed with both internal and external participants to refine the CompleTest™ training programs and ensure the device is easy-to-use.
“We have completed the design verification, testing, and certification of CompleTest™ and are excited to launch into a high growth market” stated Gary Jones, Vice President of Business Development. “The CompleTest™ was unveiled to master growers and quality assurance personnel at the recent Lift Expo in Vancouver, where over 60 live demonstrations were completed demonstrating the capabilities of our devices. The Company received positive feedback from the attendees in respect of with the simplicity, speed, accuracy, and consistency of results of the product. The Company believes that The CompleTest™ provides growers with an in-house quality assurance solution that also provides the opportunity to optimize and manage potency yields of cannabis.”
With a fast, reliable, accurate and easy-to-use in-house testing device, growers can focus on precision agriculture and optimize the potency yield of their crop without waiting for quality assurance personnel or third-party lab results. Moreover, licensed producers will have data at their fingertips to ensure third-party labs are providing accurate and consistent results.
About CompleTest™
CompleTest™ is FluroTech’s flagship brand and product line. CompleTest™ is a portable, cost-effective, state-of-the-art cannabis testing device, able to provide fast, accurate and consistent testing results. It is designed for cultivators, dispensaries and anyone with an interest in precision agriculture to optimize potency yield and consumer safety to test the quality and safety of their cannabis products.
About FluroTech (TSX-V: TEST) (OTCQB: FLURF)
FluroTech is a technology and marketing company whose core business is focused on the commercialization of new technologies in the cannabis industry. FluroTech’s proprietary spectroscopy-based technology allows for the testing and identification of organic and inorganic compounds contained within biological samples. Using the technology that was developed at the University of Calgary in conjunction with the University of Alberta, FluroTech has developed a two-part solution comprising an instrument called the CompleTest™ and consumable testing kits.
To learn more, visit www.FluroTech.com.
Contact Information
Gary Jones
VP Business Development
403.650.9277
gpjones@flurotech.com
Danny Dalla-Longa
Chief Executive Officer
403.680.0644
danny@flurotech.com
FluroTech Ltd.
Alistair Ross Technology Centre
Suite 111, 3553-31 Street NW
Calgary, AB T2L 2K7
info@flurotech.com
This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities. The securities described herein have not been and will not be registered under the United States Securities Act of 1933, as amended, or the securities laws of any state and may not be offered or sold within the United States or to or for the benefit or account of U.S. persons, absent such registration or an applicable exemption from such registration requirements.
Cautionary Statement Regarding Forward-Looking Information
This news release contains "forward-looking information" within the meaning of Canadian securities legislation. Forward-looking information generally refers to information about an issuer’s business, capital, or operations that is prospective in nature, and includes future-oriented financial information about the issuer’s prospective financial performance or financial position. The forward-looking information in this news release includes disclosure about the benefits of the Company’s CompleTest™ testing device.
The Company made certain material assumptions, including but not limited to prevailing market conditions and general business, economic, competitive, political and social uncertainties to develop the forward-looking information in this news release. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.
Actual results may vary from the forward-looking information in this news release due to certain material risk factors. These risk factors include, but are not limited to, adverse market conditions and regulatory and other risks associated with the cannabis industry in general, and users of the CompleTest™ failing to achieve the anticipated benefits of the product. The Company cautions that the foregoing list of material risk factors and assumptions is not exhaustive.
The Company assumes no obligation to update or revise the forward-looking information in this news release, unless it is required to do so under Canadian securities legislation.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy of this release.
Cool thing is that the video is made with CFN so I think it’s fair to expect a US coverage with them.
This was sent this we
Urls to videos are in
https://gallery.mailchimp.com/c0e8e4738080eb0de0d93392d/files/771d46f4-4b59-4c01-af74-dcb60390bb9c/Creating_a_Buzz.03.pdf
FluroTech’s CompleTestTM Cannabis Testing Device has been Generating a Buzz in the Cannabis Industry!
Congratulations to our team for winning the ‘Best of Show’ award in the Technology Category (from High! Canada) at the Lift Cannabis Expo in Vancouver in January 2019. We want to share with you a little bit about what makes this technology so exciting so here’s a couple of videos to introduce our testing solutions.....
The first Video is an un-rehearsed interview with FluroTech’s Director of Scientific Research and Business Development, Dr. Trevor MacMillan. Trevor joined FluroTech in September 2018 after having served for 3 years with Aurora Cannabis where he was Director of Research and Quality Control (if you are pressed for time and would like to jump straight to the testing demonstration, advance to 6:30 in the video for a 90 second demo).
The video was produced by CFN Media (LA) and records FluroTech’s first-ever public demonstrations of The CompleTestTM testing technology during the Lift Cannabis Expo in Vancouver, January 11-13, 2019. WATCH VIDEO 1 (PW is CFNlift19)
You will hear some repetition of the words “Croptimization” and “Precision Agriculture” which have quickly become core industry buzzwords. They embody the chief objective of every grower and producer in the cannabis industry as they strive for greater control and influence over the grow cycle. Optimization of yields and control of product quality present distinct and quantifiable economic and public health advantages to a grower seeking to differentiate their product and earn market share within a very competitive industry. Testing is an integral tool in that process.
The second Video, at only 90 seconds in length, is a condensed demonstration of the 20 minute testing process for THC and CBD and it further illustrates the ease of use of the CompleTestTM testing device. With the aid of a 30 minute tutorial video, in-house staff can be quickly trained to conduct a wide-range of fast and extremely accurate tests. WATCH VIDEO 2
A reminder...FluroTech testing technologies are positioned to exploit not just one, but THREE major revenue streams in the cannabis testing industry:
1) Croptimization or Precision Agriculture. In-House testing for early identification of contaminants, maximization of THC/CBD potency levels, and determination of optimal time to harvest. Current FluroTech testing technologies utilize scopes capable of accurately quantifying THC/CBD % and detecting the presence of Heavy metals (Lead, Mercury and Cadmium). Scopes under development will be capable of identifying banned pesticides and aflatoxins (produced by mold).
2) Individual Testing (Public Safety). Roadside saliva testing of individuals operating vehicles while potentially under the influence of drugs. The device will be capable of testing for THC, methamphetamine, and cocaine. The same device will be utilized by employers for testing their employees working in high-risk occupations...a very large market. The FluroTech roadside device will be submitted for review to the Drugs and Driving Committee, in Canada, by the end of Q1.
3) Biomarking. The ability to track all components of the plant right from seed through to sale. This helps suppress the influence of the black market and counterfeiting, thereby increasing government tax revenue and consumer safety (able to confirm the origin and legality of the product ...each LP would have a unique signature).
Please contact me if you’d like more information about investing in FluroTech’s game-changing testing technologies.
Robert Achtymichuk, P. Eng Director, Capital Markets FluroTech Ltd.
Suite 111, 3553-31st Street NW Calgary, Alberta T2L 2K7 rob@flurotech.com
Basically by getting the GMP certification, they’ll offer the LPs to skip any external testing required by Health Canada which will shorten the time to get their product on the shelves.
That’s pretty awesome imo
Flurotech interview from Lift Expo last week
Their presentation has been updated in their website
Not sure I understand the outcome of that. Does that means that the Memphis plant now is dependant of this new plant or it’s just that once it is validated, they’ll build a similar capability at the Memphis plant?
Anyone can explain the numbers in the latest nr?
For example
Au sample 250g/t
Light process: 185g/t distr 44% reco 89%
Concentrate: 400g/t distr 56% reco 99%
?
He simply states that until Enviroleach and Jabil put out an official news release anything could happen, including delays and other not so positive events.
No one can rely on your word that everything has been fixed because you are not an insider and management won’t risk telling anyone about what’s happening.
On the other hand, they have been there for over 3 months now and if it was a complete failure, Jabil would have stopped the Memphis plant project and they would be forced to issue a news release as this would be material info. So no news might be good news but no one really knows right now.